Preparing for regulatory submission for a pharmaceutical product can often feel like an overwhelming task. The submission process for both clinical trials and market authorization requires not only meeting ever-changing regulatory requirements for documents and label formatting, but also increasingly is a crucial way to communicate to patients and providers, making considerations around patient centricity paramount. This white paper explores why working with a certified language service provider to integrate regulatory best practices with patient-centric language is essential to providing effective medical translations for pharmaceutical labeling.